• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

Introduction to 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1)

2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine, identified by its Chemical Abstracts Service (CAS) number 42198-14-1, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This diamine derivative exhibits a unique structural framework characterized by a propane backbone substituted with a methyl group at the 2-position and an N1-(4-methylphenyl) moiety, making it a versatile intermediate in the development of advanced chemical entities.

The molecular structure of 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) consists of an aromatic ring system linked to an aliphatic chain via an amine functional group. This bifunctional nature allows for diverse chemical modifications, enabling its application in the synthesis of complex molecules such as ligands for metal coordination, building blocks for polymer chemistry, and precursors for drug candidates. The presence of both primary amine groups enhances its reactivity, making it a valuable reagent in cross-coupling reactions, hydrogenation processes, and condensation reactions.

In recent years, the pharmaceutical industry has shown increasing interest in diamine derivatives due to their potential biological activities. Specifically, 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) has been explored as a key intermediate in the synthesis of novel therapeutic agents targeting various diseases. Its structural features suggest possible interactions with biological targets such as enzymes and receptors, which are critical for drug efficacy.

One of the most compelling applications of 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) is in the field of medicinal chemistry. Researchers have utilized this compound to develop small-molecule inhibitors that modulate enzyme activity. For instance, its derivatives have been investigated for their ability to inhibit kinases and phosphodiesterases, which are implicated in signaling pathways associated with cancer and inflammatory diseases. The aromatic ring system and the flexible aliphatic chain provide a scaffold that can be modified to optimize binding affinity and selectivity.

The synthesis of 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) involves multi-step organic transformations that highlight its synthetic utility. Common synthetic routes include nucleophilic substitution reactions, reduction processes, and condensation reactions with appropriate carbonyl compounds. The choice of starting materials and reaction conditions can be tailored to achieve high yields and purity levels essential for pharmaceutical applications.

Recent advancements in catalytic methods have further enhanced the accessibility of 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1). Transition-metal-catalyzed reactions, such as palladium-catalyzed cross-coupling and copper-mediated coupling reactions, have enabled efficient construction of complex molecular architectures from simpler precursors. These catalytic approaches not only improve synthetic efficiency but also reduce waste generation, aligning with green chemistry principles.

The role of computational chemistry in designing derivatives of 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) cannot be overstated. Molecular modeling techniques allow researchers to predict the biological activity and pharmacokinetic properties of potential drug candidates before experimental synthesis. This computational screening helps in prioritizing promising compounds for further investigation, thereby accelerating the drug discovery process.

In conclusion, 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) represents a versatile and valuable compound in modern chemical synthesis and pharmaceutical research. Its unique structural features and reactivity make it an indispensable tool for chemists developing innovative solutions to complex biological challenges. As research continues to uncover new applications for this compound, 2-Methyl-N1-(4-methylphenyl)propane-1,2-diamine (CAS No. 42198-14-1) is poised to play an increasingly significant role in advancing therapeutic strategies across multiple disciplines.

• 2050-14-8(2,2'-Dihydroxyazobenzene)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)